Cefuroxime 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cefuroxime 250mg tablets

alliance healthcare (distribution) ltd - cefuroxime axetil - oral tablet - 250mg

Cefuroxime 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cefuroxime 250mg tablets

phoenix healthcare distribution ltd - cefuroxime axetil - oral tablet - 250mg

ZINNAT cefuroxime (as axetil) 250 mg/5mL granules for oral suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

zinnat cefuroxime (as axetil) 250 mg/5ml granules for oral suspension bottle

aspen pharmacare australia pty ltd - cefuroxime axetil, quantity: 300 mg (equivalent: cefuroxime, qty 250 mg) - suspension, powder for - excipient ingredients: povidone; sucrose; stearic acid; flavour - zinnat suspension is indicated for the treatment of the following mild to moderately severe infections caused by sensitive bacteria in paediatric patients aged 3 months to 12 years: tonsillitis and pharyngitis, acute bacterial otitis media. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefuroxime axetil appears to be as effective as phenoxymethylpenicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefuroxime axetil in the subsequent prevention of rheumatic fever are not available at present.